360 Financial’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,914
Closed -$31.9K 85
2024
Q4
$31.9K Hold
1,914
0.01% 82
2024
Q3
$19.4K Hold
1,914
0.01% 88
2024
Q2
$111K Hold
1,914
0.04% 85
2024
Q1
$63.7K Hold
1,914
0.02% 84
2023
Q4
$155K Hold
1,914
0.07% 78
2023
Q3
$292K Hold
1,914
0.18% 51
2023
Q2
$628K Hold
1,914
0.32% 40
2023
Q1
$528K Sell
1,914
-133
-6% -$48.8K 0.28% 47
2022
Q4
$489K Hold
2,047
0.32% 39
2022
Q3
$489K Hold
2,047
0.32% 39
2022
Q2
$537K Buy
2,047
+133
+7% +$57.2K 0.32% 37
2022
Q1
$1.36M Hold
1,914
0.66% 24
2021
Q4
$1.32M Hold
1,914
0.6% 25
2021
Q3
$1.42M Sell
1,914
-67
-3% -$45.7K 0.73% 22
2021
Q2
$1.49M Buy
+1,981
New +$1.51M 0.77% 19

Other funds holding OM

360 Financial's OM Position: Q1 2025 in Review

360 Financial sold out of Outset Medical (OM) in Q1 2025, closing a stake of 1,914 shares — an estimated $31.9K sold.

360 Financial first reported a position in OM in Q2 2021 and held it in 15 quarters. The position peaked at $1.49M in Q2 2021. 61 funds tracked by Wall St. Rank hold OM as of Q1 2025.

  • 360 Financial reported no remaining Outset Medical position as of Q1 2025 after selling out during the quarter.
  • 360 Financial sold 1,914 Outset Medical shares in Q1 2025, an estimated $31.9K.
  • 360 Financial first reported a position in Outset Medical in Q2 2021 and held it in 15 quarters.
  • 360 Financial's Outset Medical position peaked at $1.49M in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Outset Medical as of Q1 2025.

Based on 360 Financial's 13F filing for Q1 2025, filed 8 May 2025.